Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial

BACKGROUND: Sickle cell anemia (SCA) is an inherited hematological disorder that causes a large but neglected global health burden, particularly in Africa. Hydroxyurea represents the only available disease‐modifying therapy for SCA, and has proven safety and efficacy in high‐resource countries. In s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: McGann, Patrick T., Tshilolo, Léon, Santos, Brigida, Tomlinson, George A., Stuber, Susan, Latham, Teresa, Aygun, Banu, Obaro, Stephen K., Olupot‐Olupot, Peter, Williams, Thomas N., Odame, Isaac, Ware, Russell E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825070/
https://ncbi.nlm.nih.gov/pubmed/26275071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25705
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados